Source: Health Products Regulatory Authority (ZA) Revision Year: 2020 Publisher: Strides Pharma SA (Pty) Ltd, 106 16<sup>th</sup> Road, Building 2, Midrand, 1686
OSELFLU (Capsules).
Pharmaceutical Form |
---|
OSELFLU 75 mg gelatin capsule. White to off white powder filled in size “2” hard gelatin capsule with cream cap and brown body printed OP on cap and 75 on body in black. |
Each capsule contains oseltamivir phosphate equivalent to 75 mg oseltamivir.
For full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Oseltamivir |
Oseltamivir (oseltamivir carboxylate) is a selective inhibitor of influenza virus neuraminidase enzymes, which are glycoproteins found on the virion surface. Viral neuraminidase enzyme activity is important both for viral entry into uninfected cells and for the release of recently formed virus particles from infected cells, and for the further spread of infectious virus in the body. |
List of Excipients |
---|
Granules: Croscarmellose sodium Hard gelatin capsule: Gelatin Imprinting ink: Ammonia |
Carton containing 10 capsules in blister pack. Blister packs are composed of plastic (PVC/PE/PVDC) and aluminium foil.
Strides Pharma SA (Pty) Ltd, 106 16th Road, Building 2, Midrand, 1686
41/20.2.8/0798
Renewal: April 2019
Drug | Countries | |
---|---|---|
OSELFLU | Brazil, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.